Maria Cucè

MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells

N. Munshi, C. Mignogna, P. Tassone, 2017, Leukemia.

A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival

P. Tassone, P. Tagliaferri, C. Botta, 2016, Blood Cancer Journal.

A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics

M. Cannataro, P. Tassone, P. Tagliaferri, 2022, Biomedicines.

The Era of PARP inhibitors in ovarian cancer: "Class Action" or not? A systematic review and meta-analysis.

P. Tassone, P. Tagliaferri, V. Barbieri, 2018, Critical reviews in oncology/hematology.

Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma

P. Tassone, P. Tagliaferri, V. Barbieri, 2019, Journal of Hematology & Oncology.

Network meta-analysis of randomized trials in multiple myeloma: efficacy and safety in relapsed/refractory patients.

P. Tassone, P. Tagliaferri, C. Botta, 2017, Blood advances.

Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience.

P. Tassone, P. Tagliaferri, Giuseppe Agapito, 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.